about
Initial experiences with endoscopic rhino-neurosurgery in Amsterdam.Motor patterns in Parkinson's disease: a data-driven approach.Clinical and Laboratory Characteristics for the Diagnosis of Bacterial Ventriculitis After Aneurysmal Subarachnoid Hemorrhage.The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.Surgery versus prolonged conservative treatment for sciatica: 5-year results of a randomised controlled trialA comprehensive model of health-related quality of life in Parkinson's disease.Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.Age determination of subdural hematomas with CT and MRI: a systematic review.Coiling and clipping of middle cerebral artery aneurysms: a systematic review on clinical and imaging outcome.The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature.Association of Automatically Quantified Total Blood Volume after Aneurysmal Subarachnoid Hemorrhage with Delayed Cerebral Ischemia.Wound drains in non-complex lumbar surgery: a systematic review.Spinal axis imaging in non-aneurysmal subarachnoid hemorrhage: a prospective cohort study.Preventive Antibiotics and Delayed Cerebral Ischaemia in Patients with Aneurysmal Subarachnoid Haemorrhage Admitted to the Intensive Care Unit.The influence of age and approaching death on the course of nondopaminergic symptoms in Parkinson's disease.A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease.Mutational analysis of TARDBP in Parkinson's disease.Survival in Parkinson's disease. Relation with motor and non-motor features.Psychotic and compulsive symptoms in Parkinson's disease.Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay.A strategy to expeditious invasive treatment improves clinical outcome in comatose patients with aneurysmal subarachnoid haemorrhage.Patterns of motor and non-motor features in Parkinson's disease.Can excision of meningiomas be limited to resection of tumor and radiologically abnormal dura mater? Neuronavigation-guided biopsies of dural tail and seemingly normal dura mater, with a review of the literature.3D Volumetric Measurement of Neurofibromatosis Type 2-Associated Meningiomas: Association Between Tumor Location and Growth Rate.Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.Odour identification and discrimination in Dutch adults over 45 years.Additional Value of Intra-Aneurysmal Hemodynamics in Discriminating Ruptured versus Unruptured Intracranial Aneurysms.Antifibrinolytic treatment in subarachnoid hemorrhage: Harmful or beneficial?Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.The MOCA: Well-suited screen for cognitive impairment in Parkinson diseaseRelation of clinical subtypes in Parkinson's disease with survivalAssessment of psychiatric complications in Parkinson's disease: The SCOPA-PCA comparative study of odor identification and odor discrimination deficits in Parkinson's diseasePhysiotherapy in Parkinson's disease: utilisation and patient satisfactionPosterior lumbar interbody fusion with stand-alone Trabecular Metal cages for repeatedly recurrent lumbar disc herniation and back painTime intervals from subarachnoid hemorrhage to rebleedAssociation of Quantified Location-Specific Blood Volumes with Delayed Cerebral Ischemia after Aneurysmal Subarachnoid HemorrhageLetter to the Editor: Short-term ε-aminocaproic acid treatment and endovascular coil embolization
P50
Q33274941-62FE05C4-AF15-42E2-941C-1FF8FAD1C772Q33428051-A35200B7-6C32-4896-B245-EE6B373F5A5AQ33726025-39522627-0115-4BED-BBC8-ADC21605BF36Q34061985-B5948857-0960-49C0-8208-AAB6DC366681Q34119990-476E154F-CF2F-4DDF-8049-3CA7AD107518Q36854552-1BAFFE92-149D-462F-890D-8009A7B231FBQ37280767-998966D9-6029-4CD0-971B-BF7B1964537EQ37970653-44B5232F-9542-4092-964E-DC8542A84987Q38210846-7D6C6248-DC76-4FF4-AE61-22DE6AB57FE9Q38272245-E4AE7B5C-58F8-4EB4-8DB9-4D848CDCDA6AQ38824558-794EFD40-BDAC-49EF-AF92-93B318BFA06AQ38877811-637ED682-D9F4-4863-9110-C44FCB9A8E48Q38882878-8FD0CE6C-5735-486D-9E9C-AB4E67C15450Q40219505-476193C0-978C-4BD3-9776-018922343CE1Q40960155-5DBA46F4-15FD-4FAB-A167-875E32B21D00Q40972367-FDF47B2C-C8C7-4A19-A92F-A7D08F2743C3Q43551213-4AA94A76-D5CB-463B-927A-D5425060BA1AQ44252462-C7D09C36-A979-4DFC-B162-08B7B13E8A46Q44336789-7A57FE45-70DC-4916-B8A7-80BBBCFA5207Q46169445-290C3ABC-61D6-4F97-8E33-CA55E6D9E5FEQ46785542-9A23B70C-C97A-46D4-AB38-A34BE5AEE186Q47677354-D5EC314D-E18E-46BC-8007-D7F49F9ECB16Q48409698-1523C1CA-E0C5-4CDA-8A7D-2BD7E7AAC4ADQ48667926-351506C9-7453-49C6-86E7-780364BEFC1EQ50544318-7B0FA9FA-D224-4AA1-ACF9-5E8BAFD4576CQ51172907-966839B7-D27A-4ACE-A1F6-A25FA8676EE1Q51555260-0B9471DC-8FE5-4DF2-B20C-C8622E07CABEQ51697164-1EE989C3-B2C8-46C7-A382-4CA1E660CF31Q51835927-DCDC1755-52FA-4309-ACC3-5C767543DCA1Q54528587-E61C3A7E-28D0-45CA-8D08-B31DE3AA3751Q54791937-F3DFA04C-C596-46E6-B267-1D087F782CA9Q57776973-3BC6AB22-3E66-4FEA-8268-7834E060798DQ60728595-A2C1F660-3CDB-400C-A70B-C7B95094A331Q60728623-521887E8-E3F2-450F-9A54-E3E652E4E6E1Q64969732-F687A2EB-3988-4FDC-AE03-B3A0A08A6CFCQ80451649-5F73A7FE-20ED-4B89-B64C-009510853184Q87547157-7A36EC9A-D776-409B-BBD2-63878A0EFDBEQ87831564-49115793-EB2C-4F64-AA4C-BAE00345528DQ88346113-1AAF8077-8CA5-4660-B44C-D7CFAD58F2DBQ88787801-D1F1C539-B725-4765-8229-D55ADE9832A0
P50
description
Forscherin
@de
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dagmar Verbaan
@ast
Dagmar Verbaan
@bar
Dagmar Verbaan
@de
Dagmar Verbaan
@en
Dagmar Verbaan
@es
Dagmar Verbaan
@fr
Dagmar Verbaan
@nl
Dagmar Verbaan
@sl
type
label
Dagmar Verbaan
@ast
Dagmar Verbaan
@bar
Dagmar Verbaan
@de
Dagmar Verbaan
@en
Dagmar Verbaan
@es
Dagmar Verbaan
@fr
Dagmar Verbaan
@nl
Dagmar Verbaan
@sl
prefLabel
Dagmar Verbaan
@ast
Dagmar Verbaan
@bar
Dagmar Verbaan
@de
Dagmar Verbaan
@en
Dagmar Verbaan
@es
Dagmar Verbaan
@fr
Dagmar Verbaan
@nl
Dagmar Verbaan
@sl
P106
P21
P31
P4012
P496
0000-0002-9212-5470